News & Events

cobas® Liat® PCR System swift diagnosis

Roche Receives FDA CLIA Waiver for Flu A/B Test for use on its cobas® Liat® PCR System.

Roche today announced that the U.S. Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) Waiver for the cobas® Influenza A/B test for use on the cobas® Liat® System.

Read more
Strep A Virus

Roche Receives FDA CLIA Waiver for the cobas® Liat® PCR System and cobas® Strep A Assay

cobas® Strep A, the first molecular PCR test to deliver laboratory-quality results in ~15 minutes, now available for use in physician offices and pharmacies

Read more
cobas® Liat® PCR System Assay Tube Scan

Roche Launches PCR Molecular Diagnostic System for Point-of-Care Environment

The cobas® Liat® System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less

Read more
cobas® Liat® security login screen

Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (English)

The cobas® Strep A test is the first molecular point of care test to provide a result in 15 minutes for this common infection

Read more
cobas® Liat® security login screen

Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (French)

Le test cobas® Strep A est le premier test moléculaire réalisé au point de soins qui offre un résultat en 15 minutes pour cette infection courante

Read more
cobas® Liat® security login screen

Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (Spanish)

La prueba cobas® Strep A es la primera prueba molecular de análisis inmediato que proporciona un resultado en 15 minutos para esta infección tan común

Read more